Literature DB >> 1730528

Enhanced CMP-NeuAc:Gal beta 1,4GlcNAc-R alpha 2,6 sialyltransferase activity of human colon cancer xenografts in athymic nude mice and of xenograft-derived cell lines.

F Dall'Olio1, N Malagolini, F Serafini-Cessi.   

Abstract

The activity of an alpha 2,6 sialyltransferase acting on N-acetyllactosaminic sequences (alpha 2,6 ST E.C. 2.4.99.1) has previously been found to be increased in 90% of human colon cancer specimens. In the present study, the alpha 2,6 ST activity of 6 human colon cancer cell lines grown in culture was compared with that expressed by the corresponding nude mice xenografts and by the cell lines derived from the xenografts. We found that xenografts of COLO 205, HT-29, SW 620, SW 948 and SW 948 FL (a non-adherent sub-line of SW 948) cells express an alpha 2,6 ST activity much higher than that of the in vitro-grown cells. SW 48 cells grown either in culture or as xenografts lack the enzyme activity. All the xenograft-derived cell lines except HT-29 retained the increased alpha 2,6 ST activity at least for the first 6 passages. Those derived from SW 948 xenografts showed an enrichment of round, non-adherent cells, strongly reactive with the NeuAc alpha 2,6 Gal/GalNAc-specific lectin from Sambucus nigra (SNA), thus indicating that a selection of these cells has occurred.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1730528     DOI: 10.1002/ijc.2910500227

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  9 in total

Review 1.  Sialyltransferases in cancer.

Authors:  F Dall'Olio; M Chiricolo
Journal:  Glycoconj J       Date:  2001 Nov-Dec       Impact factor: 2.916

2.  Protein glycosylation in cancer biology: an overview.

Authors:  F Dall'olio
Journal:  Clin Mol Pathol       Date:  1996-06

3.  Differentiation -dependent expression of human beta-galactoside alpha 2,6-sialyltransferase mRNA in colon carcinoma CaCo-2 cells.

Authors:  F Dall'Olio; N Malagolini; S Guerrini; J T Lau; F Serafini-Cessi
Journal:  Glycoconj J       Date:  1996-02       Impact factor: 2.916

4.  Altered mRNA expression of glycosyltransferases in human colorectal carcinomas and liver metastases.

Authors:  T Petretti; W Kemmner; B Schulze; P M Schlag
Journal:  Gut       Date:  2000-03       Impact factor: 23.059

5.  Correlation and prognostic significance of beta-galactoside alpha-2,6-sialyltransferase and serum monosialylated alpha-fetoprotein in hepatocellular carcinoma.

Authors:  Terence C W Poon; Clarissa H S Chiu; Paul B S Lai; Tony S K Mok; Benny Zee; Anthony T C Chan; Joseph J Y Sung; Philip J Johnson
Journal:  World J Gastroenterol       Date:  2005-11-14       Impact factor: 5.742

Review 6.  The sialyl-alpha2,6-lactosaminyl-structure: biosynthesis and functional role.

Authors:  F Dall'Olio
Journal:  Glycoconj J       Date:  2000-10       Impact factor: 2.916

7.  Different sialyltransferase activities in human colorectal carcinoma cells from surgical specimens detected by specific glycoprotein and glycolipid acceptors.

Authors:  W Kemmner; D Krück; P Schlag
Journal:  Clin Exp Metastasis       Date:  1994-05       Impact factor: 5.150

8.  Tumor cell migration and invasion are regulated by expression of variant integrin glycoforms.

Authors:  Faheem M Shaikh; Eric C Seales; William C Clem; Kristin M Hennessy; Ya Zhuo; Susan L Bellis
Journal:  Exp Cell Res       Date:  2008-07-30       Impact factor: 3.905

9.  Purification and characterization of a novel beta-D-galactosides-specific lectin from Clitoria ternatea.

Authors:  Aabgeena Naeem; Shabirul Haque; Rizwan Hasan Khan
Journal:  Protein J       Date:  2007-09       Impact factor: 2.371

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.